采用新型波前传感器技术的波前引导准分子原位角膜磨镶术治疗近视的安全性和有效性：首批100例病例
Safety and efficacy of wavefront-guided myopic laser in situ keratomileusis using a new wavefront sensor technology: first 100 cases.
作者信息
Smadja David, Santhiago Marcony R, Tellouck Joy, De Castro Tania, Lecomte Fanny, Mello Glauco R, Touboul David
机构信息
From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.
From the Ophthalmology Department, Tel Aviv Sourasky Medical Center (Smadja), and the Institute of Nanotechnology and Advanced Materials (Smadja), Bar-Ilan University, Tel Aviv, Israel; the National Reference Center for Keratoconus (Smadja, Tellouck, De Castro, Lecomte, Touboul), Bordeaux Hospital University, Bordeaux, France; Department of Ophthalmology (Santhiago), Federal University of Rio De Janeiro, Rio, Brazil, Department Of Ophthalmology (Mello), Federal University Of Paraná, Curitiba, Brazil.
出版信息
J Cataract Refract Surg. 2015 Aug;41(8):1588-93. doi: 10.1016/j.jcrs.2014.11.053.
PURPOSE
To evaluate the safety and efficacy of wavefront-guided laser in situ keratomileusis (LASIK) for the correction of low to high myopia and myopic astigmatism using data derived from a new-generation Hartmann-Shack aberrometer.
SETTING
Refractive Surgery Unit, Bordeaux Hospital University, France.
DESIGN
Retrospective case series.
METHODS
This retrospective study analyzed the initial group of eyes treated with wavefront-guided LASIK for myopia and myopic astigmatism using the Visx S4IR excimer laser and wavefront data derived from a new Hartmann-Shack aberrometer (iDesign Advanced Wavescan aberrometer). Refractive (refraction and refractive accuracy) and visual outcomes (uncorrected [UDVA] and corrected [CDVA] distance visual acuities) were recorded 3 months postoperatively.
RESULTS
The study included 100 eyes of 50 consecutively treated patients. The mean decimal UDVA improved from 0.1 ± 0.1 (SD) preoperatively to 1.1 ± 0.15 postoperatively (P < .01). A monocular UDVA of 20/16, 20/20, and 20/25 were achieved in 76.6%, 94.4%, and 96.6% of eyes, respectively. The postoperative manifest spherical equivalent was within ±0.5 diopter in all eyes. No eye lost 2 or more lines of CDVA, and 29.2% of the eyes gained 1 or more lines of CDVA.
CONCLUSION
Wavefront-guided LASIK performed using data derived from the new Hartmann-Shack aberrometer was safe, effective, and predictable for treating myopia and myopic astigmatism.
FINANCIAL DISCLOSURE
No author has a financial or proprietary interest in any material or method mentioned.
目的
利用新一代哈特曼-夏克像差仪获取的数据，评估波前引导的准分子原位角膜磨镶术（LASIK）矫正低至高度近视及近视散光的安全性和有效性。
设置
法国波尔多大学医院屈光手术科。
设计
回顾性病例系列。
方法
这项回顾性研究分析了首批接受波前引导LASIK治疗近视及近视散光的患者，使用的是威视S4IR准分子激光以及来自新型哈特曼-夏克像差仪（iDesign Advanced Wavescan像差仪）的波前数据。术后3个月记录屈光（验光和屈光精度）及视觉结果（未矫正远视力[UDVA]和矫正远视力[CDVA]）。
结果
该研究纳入了50例连续接受治疗患者的100只眼。平均小数视力UDVA从术前的0.1±0.1（标准差）提高到术后的1.1±0.15（P<.01）。分别有76.6%、94.4%和96.6%的眼单眼UDVA达到20/16、20/20和2 /25。所有眼术后明显球镜等效度均在±0.5屈光度范围内。没有眼的CDVA下降2行或更多，29.2%的眼CDVA提高了1行或更多。
结论
使用新型哈特曼-夏克像差仪获取的数据进行波前引导LASIK治疗近视及近视散光是安全、有效且可预测性的。
财务披露
没有作者对文中提及的任何材料或方法拥有财务或专利权益。
Zotero 插件